"Hang in there chicagoest, I'm pretty sure we will have answers to your concerns in the near future."

tada 

I must say - I had my hopes up today for some good news - 

I learned that with respect to the Covid therapeutic - the 2b trial is a long way away from full enrollment of just 100 patients - and that recruiting is taking place in Resverlogix home territory. So - just getting started in Brazil. Estimated primary completion date of 3/22/22 will undoubtedly be kicked down the road - no mention of EUA in Canada around mid-year - no answer on debenture financing - looks like an equity conversion at .30 -.40 CAD by the time 5/13/22 rolls around - how about 2022 revenues -

Unfortunately no good answers - that video was disconcerting to say the least

Chicagoest